Page 216 - 2019_04-Haematologica-web

Ferrata Storti Foundation
Haematologica 2019 Volume 104(4):844-854
Blood Transfusion
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors
Michael A. Pulsipher,1 Brent R. Logan,2 Deidre M. Kiefer,3
Pintip Chitphakdithai,3 Marcie L. Riches,4 J. Douglas Rizzo,2 Paolo Anderlini,5 0Susan F. Leitman,6 Hati Kobusingye,3 RaeAnne M. Besser,3 John P. Miller,7 Rebecca J. Drexler,3 Aly Abdel-Mageed,8 Ibrahim A. Ahmed,9
Luke P. Akard,10 Andrew S. Artz,11 Edward D. Ball,12 Ruthee-Lu Bayer,13
Carolyn Bigelow,14 Brian J. Bolwell,15 E. Randolph Broun,16 David C. Delgado,17 Katharine Duckworth,18 Christopher C. Dvorak,19 Theresa E. Hahn,20
Ann E. Haight,21 Parameswaran N. Hari,22 Brandon M. Hayes-Lattin,23
David A. Jacobsohn,24 Ann A. Jakubowski,25 Kimberly A. Kasow,26
Hillard M. Lazarus,27 Jane L. Liesveld,28 Michael Linenberger,29
Mark R. Litzow,30 Walter Longo,31 Margarida Magalhaes-Silverman,32
John M. McCarty,33 Joseph P. McGuirk,34 Shahram Mori,35
Vinod Parameswaran,36 Vinod K. Prasad,37 Scott D. Rowley,38
Witold B. Rybka,39 Indira Sahdev,40 Jeffrey R. Schriber,41 George B. Selby,42 Paul J. Shaughnessy,43 Shalini Shenoy,44 Thomas Spitzer,45 William T. Tse,46 Joseph P. Uberti,47 Madhuri Vusirikala,48 Edmund K. Waller,49
Daniel J. Weisdorf,50 Gregory A. Yanik,51 Willis H. Navarro,3
Mary M. Horowitz,2 Galen E. Switzer,52 Dennis L. Confer3,7
and Bronwen E. Shaw2
1Children's Hospital Los Angeles, CA; 2Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; 3Center for International Blood and Marrow Transplant Research, Division of Biostatistics, Minneapolis, MN; 4University of North Carolina Hospitals, Division of Hematology and Oncology Chapel Hill, NC; 5Department of Stem Cell Transplantation and Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX; 6Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD; 7National Marrow Donor Program/Be The Match, Minneapolis, MN; 8Department of Pediatrics and Human Development, Helen DeVos Children's Hospital, Grand Rapids, MI; 9Department of Hematology and Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO; 10Indiana Blood and Marrow Transplantation, Indianapolis, IN; 11University of Chicago Hospitals, IL; 12University of California, San Diego Medical Center, La Jolla, CA; 13North Shore University Hospital, Manhasset, NY; 14University of Mississippi Medical Center, Jackson, MS; 15Taussig Cancer Institute, Cleveland Clinic Foundation, OH; 16Jewish Hospital, Cincinnati, OH; 17Indiana University Hospital/Riley Hospital for Children, IN; 18Wake Forest University Baptist Medical Center, Winston-Salem, NC; 19Division of Pediatric Blood and Marrow Transplantation, University of California San Francisco Benioff Children’s Hospital, CA; 20Roswell Park Cancer Institute, Buffalo, NY; 21Aflac Cancer and Blood Disorders Center, Division of Hematology/Oncology-Bone Marrow Pediatric Hematology & Medical Oncology, Children’s Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA; 22Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; 23Doernbecher Children's Hospital, Oregon Health & Science University, Portland, OR; 24Children's National Medical Center, Washington DC; 25Memorial Sloan Kettering Cancer Center – Adult, New York, NY; 26Pediatric Hematology Oncology Program, Bone Marrow and Stem Cell Transplantation Program, University of North Carolina Healthcare, Chapel Hill, NC; 27Seidman Cancer Center-University Hospitals Cleveland Medical Center, OH; 28Strong Memorial Hospital - University of Rochester Medical Center, NY; 29Division of Hematology, Fred Hutchinson Cancer Research Center, Seattle, WA; 30Division of Hematology, Mayo Clinic Rochester, MN; 31University of Wisconsin Hospital and Clinics, Madison, WI; 32Blood and Marrow Transplant Program, University of Iowa Hospitals & Clinics, Iowa City, IA; 33Virginia Commonwealth University Massey Cancer Center Bone Marrow Transplant Program, Richmond, VA; 34University of Kansas, Westwood, KS; 35Florida Hospital Cancer Institute, Florida Center for Cellular Therapy, Orlando, FL; 36Avera McKennan Transplant Institute, Sioux Falls, SD; 37Duke Cancer Institute, Duke University Medical Center, Durham, NC; 38Hackensack University Medical Center, Washington DC; 39Penn State Health Milton S. Hershey Medical Center, PA; 40Cohen Children’s Medical Center of New York, New Hyde Park, NY; 41Cancer Transplant Institute Honor Health, Scottsdale, AZ; 42HCA Health Services of Oklahoma, Inc., University of Oklahoma, Oklahoma City, OK; 43Texas Transplant Institute, San Antonio, TX; 44Division of Hematology/Oncology, St. Louis Children's Hospital, MO; 45Massachusetts General Hospital, Boston, MA; 46Ann & Robert H. Lurie Children's Hospital of Chicago, IL; 47Karmanos Cancer Institute, Detroit, MI; 48Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX; 49Emory University Hospital, Atlanta, GA; 50University of Minnesota Medical Center, Fairview, Minneapolis, MN; 51The University of Michigan, Ann Arbor, MI and 52Division of General Internal Medicine, University of Pittsburgh, PA, USA
Correspondence:
MICHAEL A. PULSIPHER
mpulsipher@chla.usc.edu
Received: June 21, 2018. Accepted: October 30, 2018. Pre-published: October 31, 2018.
doi:10.3324/haematol.2018.200121
Check the online version for the most updated information on this article, online supplements, and information on authorship & disclosures: www.haematologica.org/content/104/4/844
©2019 Ferrata Storti Foundation
Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or inter- nal use. Sharing published material for non-commercial pur- poses is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for com- mercial purposes is not allowed without permission in writing from the publisher.
844
haematologica | 2019; 104(4)
ARTICLE